• 1
    AIHW. Cancer in Australia: An Overview. Canberra, ACT: AIHW, 2008: Cancer Series no. 46, Cat. no. CAN 42
  • 2
    Ryu SI, Chang SD, Kim DH et al. Image-guided hypo-fractionated stereotactic radiosurgery to spinal lesions. Neurosurgery 2001; 49: 83846
  • 3
    American Cancer Society. Cancer Facts & Figures 2011. Atlanta, NJ: American Cancer Society, 2011
  • 4
    Leksell L. The stereotaxic method and radiosurgery of the brain. Acta Chir Scand 1951; 102: 3169
  • 5
    Lax I, Blomgren H, Näslund I, Svanström R. Stereotactic radiotherapy of malignancies in the abdomen: methodological aspects. Acta Oncol 1994; 33: 67783
  • 6
    Andrews DW, Scott CB, Sperduto PW et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004; 363: 166572
  • 7
    Timmerman R, Paulus R, Galvin J et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010; 303: 10706
  • 8
    Siva S, MacManus M, Ball D. Stereotactic radiotherapy for pulmonary oligometastases: a systematic review. J Thoracic Oncol 2010; 5: 10919
  • 9
    Herfarth KK, Debus J, Lohr F et al. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 2001; 19: 16470
  • 10
    Pan H, Simpson DR, Mell LK, Mundt AJ, Lawson JD. A survey of stereotactic body radiotherapy use in the United States. Cancer 2011; 117: 456672
  • 11
    Mahadevan A, Miksad R, Goldstein M et al. Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer. Int J Radiat Oncol Biol Phys 2011; 81: e61522
  • 12
    Hanley J, Debois MM, Mah D et al. Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation. Int J Radiat Oncol Biol Phys 1999; 45: 60311
  • 13
    Murphy MJ. Tracking Moving Organs in Real Time. Amsterdam: Elsevier, 2004: 91100
  • 14
    Ozhasoglu C, Murphy MJ. Issues in respiratory motion compensation during external-beam radiotherapy. Int J Radiat Oncol Biol Phys 2002; 52: 138999
  • 15
    Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989; 62: 67994
  • 16
    Guerrero M, Li XA. Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy. Phys Med Biol 2004; 49: 482535
  • 17
    Dawson LA, Jaffray DA. Advances in image-guided radiation therapy. J Clin Oncol 2007; 25: 93846
  • 18
    Ning S, Trisler K, Wessels BW, Knox SJ. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts. Cancer 1997; 80: 251928
  • 19
    Walsh L, Stanfield JL, Cho LC et al. Efficacy of ablative high-dose-per-fraction radiation for implanted human renal cell cancer in a nude mouse model. Eur Urol 2006; 50: 795800
  • 20
    Ponsky L, Crownover R, Rosen M et al. Initial evaluation of cyberknife technology for extracorporal renal tissue ablation. Urology 2003; 61: 498501
  • 21
    Kaplan ID, Redrosa I, Martin C, Collins C, Wagner A. Results of a phase I dose escalation study of stereotactic radiosurgery for primary renal tumors. Int J Radiat Oncol Biol Phys 2009; 78: S191S
  • 22
    Ponsky L, Vricella G. Radiosurgery for renal tumors. In Ponsky LE, Fuler DB, Meier RM, Ma C eds, Robotic radiosurgery treating prostate cancer and related genitourinary applications, Berlin: Springer-Verlag, 2012: 17984
  • 23
    Nomiya T, Tsuji H, Hirasawa N et al. Carbon ion radiation therapy for primary renal cell carcinoma: initial clinical experience. Int J Radiat Oncol Biol Phys 2008; 72: 82833
  • 24
    Wersäll PJ, Blomgren H, Lax I et al. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother Oncol 2005; 77: 8895
  • 25
    Riches E. The place of radiotherapy in the management of parenchymal carcinoma of the kidney. J Urol 1966; 95: 3137
  • 26
    Juusela H, Malmio K, Alfthan O, Oravisto KJ. Preoperative irradiation in the treatment of renal adenocarcinoma. Scand J Urol Nephrol 1977; 11: 27781
  • 27
    Kjaer M, Iversen P, Hvidt V et al. A randomized trial of postoperative radiotherapy versus observation in stage II and III renal adenocarcinoma. Scand J Urol Nephrol 1987; 21: 2859
  • 28
    Kjaer M, Frederiksen PL, Engelholm S. Postoperative radiotherapy in stage II and III renal adenocarcinoma. A randomized trial by the Copenhagen Renal Cancer Study Group. Int J Radiat Oncol Biol Phys 1987; 13: 66572
  • 29
    Finney R. The value of radiotherapy in the treatment of hypernephroma, a clinical trial. Br J Urol 1973; 45: 25869
  • 30
    Tunio MA, Hashmi A, Rafi M. Need for a new trial to evaluate postoperative radiotherapy in renal cell carcinoma: a meta-analysis of randomized controlled trials. Ann Oncol 2010; 21: 183945
  • 31
    Michalski JM. Kidney, renal pelvis, and ureter. In Perez CA, Brady LW, Halperin EC, Schmidt-Ullrich R eds, Principles and Practice of Radiation Therapy, Philadelphia, PA: Lippincott Williams & Wilkins, 2004: 164963
  • 32
    Sheehan JP, Sun MH, Kondziolka D, Flickinger J, Lunsford LD. Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control. J Neurosurg 2003; 98: 3429
  • 33
    Payne BR, Prasad D, Szeifert G, Steiner M, Steiner L. Gamma surgery for intracranial metastases from renal cell carcinoma. J Neurosurg 2000; 92: 7605
  • 34
    Goyal LK, Suh JH, Reddy CA, Barnett GH. The role of whole brain radiotherapy and stereotactic radiosurgery on brain metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys 2000; 47: 100712
  • 35
    Amendola BE, Wolf A, Coy SR, Amendola MA. Radiosurgery as palliation for brain metastases: a retrospective review of 72 patients harboring multiple lesions at presentation. J Neurosurg 2002; 97: 5114
  • 36
    Schoggl A, Kitz K, Ertl A, Dieckmann K, Saringer W, Koos WT. Gamma-knife radiosurgery for brain metastases of renal cell carcinoma: results in 23 patients. Acta Neurochir 1998; 140: 54955
  • 37
    Mori Y, Kondziolka D, Flickinger JC, Logan T, Lunsford LD. Stereotactic radiosurgery for brain metastasis from renal cell carcinoma. Cancer 1998; 83: 34453
  • 38
    Lee SP, Leu MY, Smathers JB, McBride WH, Parker RG, Withers HR. Biologically effective dose distribution based on the linear quadratic model and its clinical relevance. Int J Radiat Oncol Biol Phys 1995; 33: 37589
  • 39
    Kunkle DA, Uzzo RG. Cryoablation or radiofrequency ablation of the small renal mass. Cancer 2008; 113: 267180
  • 40
    Svedman C, Karlsson K, Rutkowska E et al. Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney. Acta Oncol 2008; 47: 157883
  • 41
    Teh B, Bloch C, Galli-Guevara M et al. The treatment of primary and metastatic renal cell carcinoma (RCC) with image-guided stereotactic body radiation therapy (SBRT). Biomed Imaging Interv J 2007; 3: e6
  • 42
    Dawson LA, Kavanagh BD, Paulino AC et al. Radiation-associated kidney injury. Int J Radiat Oncol Biol Phys 2010; 76: S10815
  • 43
    Ramsey CR, Scaperoth D, Arwood D, Oliver AL. Clinical efficacy of respiratory gated conformal radiation therapy. Med Dosim 1999; 24: 1159
  • 44
    Qian G, Lowry J, Silverman P, Grosman I, Makara D, Lederman G. Stereotactic extra-cranial radiosurgery for renal cell carcinoma. Int J Radiat Oncol Biol Phys 2003; 57: S283
  • 45
    Beitler JJ, Makara D, Silverman P, Lederman G. Definitive, high-dose-per-fraction, conformal, sterotactic external radiation for renal cell carcinoma. Amer J Clin Oncol 2004; 27: 646
  • 46
    Gilson B, Lederman G, Qian G, Fastaia M, Cangiane L. 2249: Hypo-fractionated Stereotactic Extra-Cranial Radiosurgery (HFSR) for Primary and Metastatic Renal Cell Carcinoma. Int J Radiat Oncol Biol Phys 2006; 66: S349
  • 47
    Svedman C, Sandstrom P, Pisa P et al. A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma. Acta Oncol 2006; 45: 8705